medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 3

<< Back Next >>

Med Int Mex 2024; 40 (3)

Clinical and biochemical characteristics of the class I obesity patient in Mexico

Nachón GFJ, Saldaña DGE, Nachón AN, Ochoa MC

Language: Spanish
References: 22
Page: 201-210
PDF size: 212.29 Kb.


ABSTRACT

Objective: To describe clinical, biochemical and psycho-emotional characteristics of Mexican patients with class I obesity.
Materials and Methods: Cross-sectional study of clinical, biochemical, psychoemotional and physical activity characteristics in patients aged 18 to 60 years with body mass index between 30 and 34.9 kg/m2.
Results: There were included 90 participants. Average excess weight of 23.2 kg was found secondary to 40.1% of total body fat, and visceral fat of 139 cm2; 56.8% of the patients had abnormal blood pressure, 13.1% alterations in blood glucose, all had positive blood ketone levels; 35.5% had alterations in liver enzymes and 50.6% had dyslipidemia; 21% agreed to perform more than 120 min/week of physical activity; 41.2% showed some degree of depression and less than 10% some degree of anxiety.
Conclusions: Patients with class I obesity are not free of clinical or metabolic alterations.


REFERENCES

  1. Trends in adult body-mass index in 200 countries from1975 to 2014: a pooled analysis of 1698 population-basedmeasurement studies with 19.2 million participants. Lancet 2016; 387 (10026): 1377-96. http://dx.doi.org/10.1016/s0140-6736(16)30054-x.

  2. Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E,Heredia-Hernández O, Mojica-Cuevas J, Cuevas-Nasu L,et al. Encuesta Nacional de Salud y Nutrición 2018-19:metodología y perspectivas. Salud Pública Méx 2019; 61(6): 917-923. https://doi.org/10.21149/11095.

  3. Obesidad. Quién.int. https://www.who.int/es/healthtopics/obesity.

  4. Bray GA, Frühbeck G, Ryan DH, Wilding JPH. Managementof obesity. Lancet 2016; 387 (10031): 1947-56. http://dx.doi.org/10.1016/S0140-6736(16)00271-3.

  5. Blüher M. Metabolically healthy obesity. Endocr Rev2020; 41 (3): 405-20. http://dx.doi.org/10.1210/endrev/bnaa004.

  6. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG,Donato KA, et al. 2013 AHA/ACC/TOS guideline for themanagement of overweight and obesity in adults: a reportof the American College of Cardiology/American Heart AssociationTask Force on Practice Guidelines and The ObesitySociety. Circulation 2014; 129 (25 Suppl 2): S102-38. http://dx.doi.org/10.1161/01.cir.0000437739.71477.

  7. Who.int. [citado el 7 de septiembre de 2022]. Disponible en:https://apps.who.int/iris/bitstream/handle/10665/42132/WHO_TRS_854_spa.pdf?sequen- ce=1&isAllowed=y

  8. Diagnóstico. Diabetes.org. https://diabetes.org/diagnostico.

  9. Krishnan A, Levin A, Yu A, Chertow GM, Luyckx VA, MarsdenPA, et al. Laboratory assessment of kidney disease:glomerular filtration rate, urinalysis, and proteinuria. En:Brenner and Rector's The Kidney. Philadelphia, PA: Elsevier;11th ed. 2019.

  10. Padrós Blázquez F, Montoya Pérez KS, Bravo Calderón MA,Martínez Medina MP. 2020. Propiedades psicométricasdel Inventario de Ansiedad de Beck (BAI, Beck AnxietyInventory) en población general de México. Ansiedad yestrés 2020; 26 (2-3): 181-187. https://doi.org/10.1016/j.anyes.2020.08.002.

  11. Aguilar Aguilar CK, Blanco Castillo L, Villarreal Ríos E, VargasDaza ER, Galicia Rodríguez L, Martínez González L. Asociaciónde sobrepeso u obesidad con trastornos del estadode ánimo en adolescentes. Arch Latinoam Nutr 2018; 64 (4):321-327. https://www.doi.org/10.37527/2018.68.4.005.

  12. Lles S, Becerra Darriba A, Gastón A, Lucas S, Martínez O,Lópes M, et al. Utilidad del cuestionario de sobreingestaalimentaria en la exploración psicológica previa a la cirugíabariátrica Nutr Clin Diet Hosp 2017; 37: 56-64. http://dx.doi.org/10.12873/372pelegrin.

  13. Caballero B. Humans against obesity: Who will win? AdvNutr 2019; 10 (suppl_1): S4-9. http://dx.doi.org/10.1093/advances/nmy055.

  14. Non communicable diseases. Global Action Plan for thePrevention and Control of NCDs 2013-2020 [Internet].Who.int. World Health Organization; 2013. https://www.who.int/publications/i/item/9789241506236.

  15. INEGI. Estadística de defunciones registradas de enero ajunio de 2021 (preliminar). 24 de enero de 2022. https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2022/dr/dr2021.pdf.

  16. Polyzos SA, Kountouras J, Mantzoros CS. Obesity andnonalcoholic fatty liver disease: From pathophysiology totherapeutics. Metabolism 2019; 92: 82-97. http://dx.doi.org/10.1016/j.metabol.2018.11.014.

  17. Piña-Pozas, M, et al. Hipertensión arterial un problema desalud pública en México. Hipertensión y COVID-19. InstitutoNacional de Salud Pública, Gobierno de México, 21 July2020. www.insp.mx/avisos/5398-hipertension-arterialproblema-salud-publica.html.

  18. Clínica Las Condes – Líder en Atención. Clinicalascondes.cl. https://www.clinicalascondes.cl/CENTROS-Y-ESPECIALIDADES/Centros/Centro-de-Diabetes-Infantil/%C2%BFQueson-las-cetonas-.

  19. Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: Thestate of the disease. Gastroenterology 2020; 158 (7): 1851-64DOI: http://dx.doi.org/10.1053/j.gastro.2020.01.052.

  20. Escobedo-De La Peña J, Pérez RJ, Schargrodsky H, ChampagneB. Prevalencia de dislipidemias en la ciudad deMéxico y su asociación con otros factores de riesgo cardiovascular.Resultados del estudio CARMELA. Gac MédMéx 2014; 150: 128-36.

  21. Gob.mx. 2017 [citado el 7 de septiembre de 2022]. http://comunicacion.senado.gob.mx/index.php/informacion/boletines/39699-14-3-de-la-poblacion-mexicana-padecetrastornos-de-ansiedad.html.

  22. Instituto Nacional de Estadística y Geografía. EncuestaNacional de Bienestar Autorreportado (ENBIARE) 2021.https://www.inegi.org.mx/programas/enbiare/2021/.




2020     |     www.medigraphic.com